Measuring Blood Pressure by Inserting Finger... Daewoong Pharmaceutical to Distribute Ring-Type Blood Pressure Monitor Next Month

Ring-type continuous blood pressure monitor 'Kat BP'
Technology and usefulness presented at European Society of Cardiology
Daewoong Pharmaceutical to start domestic distribution next month

Daewoong Pharmaceutical's ring-type 24-hour continuous blood pressure monitor 'CART BP,' scheduled for domestic distribution next month, has attracted attention at an international conference.

Ring-type continuous blood pressure monitor 'Cart BP'
Photo by Daewoong Pharmaceutical

Daewoong Pharmaceutical announced on the 12th that research analyzing the technology and usefulness of Skylabs' CART BP received favorable reviews at the 'European Society of Cardiology Annual Congress (ESC Congress 2023)' held from the 25th to the 28th of last month in Amsterdam, Netherlands.

CART BP is a ring-type cuffless continuous blood pressure monitor developed by the digital healthcare startup Skylabs.

Clinical research results using CART BP were introduced in a presentation titled 'Clinical Impact of Wearable Cuffless Devices' conducted by Professor Lee Haeyoung of the Department of Cardiology at Seoul National University Hospital. Professor Lee presented the 'photoplethysmography (PPG)' technology, which measures blood pressure using light, and the deep learning-based CART BP as examples that enhanced patient comfort and adherence. Based on data from 4,185 patients, Professor Lee also emphasized the measurement accuracy of CART BP, which meets international standards.

Daewoong Pharmaceutical signed an exclusive domestic distribution agreement for CART BP with Skylabs in June and plans to begin full-scale distribution to hospitals and clinics nationwide starting in October. Daewoong Pharmaceutical explained that CART BP, worn on the finger, is expected to gain attention due to its minimal discomfort even during nighttime use. Conventional cuff-type 24-hour blood pressure monitors, which must be worn on the body, often cause sleep disturbances and pain due to repeated pressure.

Daewoong Pharmaceutical plans to first launch CART BP for hospital use and then introduce it to the general consumer online market. The company aims to achieve cumulative domestic sales exceeding 70 billion KRW over the next three years.

Lee Chang-jae, CEO of Daewoong Pharmaceutical, stated, "We expect synergy effects from the combination of Skylabs' innovation, which is standing out in the domestic and international chronic disease monitoring market, and Daewoong Pharmaceutical's differentiated four-step verified marketing strategy. Through CART BP, the world's first ring-type continuous blood pressure monitor attracting global medical attention, we will change the paradigm of hypertension diagnosis and treatment and contribute to improving patients' quality of life."

Meanwhile, Daewoong Pharmaceutical has entered the related market with cardiovascular drugs such as antihypertensives, anticoagulants, and lipid-lowering agents, as well as devices like the electrocardiogram device 'MobiCare' and the continuous glucose monitor 'FreeStyle Libre.' The company expects that adding CART BP will enhance its competitiveness.

At the European Society of Cardiology Annual Congress (ESC Congress 2023), Professor Lee Haeyoung from the Department of Cardiology at Seoul National University Hospital presented research results using the ring-type wearable blood pressure monitor, Cart BP.
[Photo by Daewoong Pharmaceutical]

This content was produced with the assistance of AI translation services.